IL131803A0 - Method for improving the efficiency of cancer gene therapy - Google Patents

Method for improving the efficiency of cancer gene therapy

Info

Publication number
IL131803A0
IL131803A0 IL13180399A IL13180399A IL131803A0 IL 131803 A0 IL131803 A0 IL 131803A0 IL 13180399 A IL13180399 A IL 13180399A IL 13180399 A IL13180399 A IL 13180399A IL 131803 A0 IL131803 A0 IL 131803A0
Authority
IL
Israel
Prior art keywords
improving
efficiency
gene therapy
cancer gene
cancer
Prior art date
Application number
IL13180399A
Original Assignee
Genena Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genena Ltd filed Critical Genena Ltd
Priority to IL13180399A priority Critical patent/IL131803A0/en
Priority to AU70369/00A priority patent/AU7036900A/en
Priority to PCT/IL2000/000546 priority patent/WO2001018056A2/en
Publication of IL131803A0 publication Critical patent/IL131803A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13180399A 1999-09-08 1999-09-08 Method for improving the efficiency of cancer gene therapy IL131803A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL13180399A IL131803A0 (en) 1999-09-08 1999-09-08 Method for improving the efficiency of cancer gene therapy
AU70369/00A AU7036900A (en) 1999-09-08 2000-09-08 Method of gene therapy for improving the efficiency of cancer therapy
PCT/IL2000/000546 WO2001018056A2 (en) 1999-09-08 2000-09-08 Method of gene therapy for improving the efficiency of cancer therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13180399A IL131803A0 (en) 1999-09-08 1999-09-08 Method for improving the efficiency of cancer gene therapy

Publications (1)

Publication Number Publication Date
IL131803A0 true IL131803A0 (en) 2001-03-19

Family

ID=11073227

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13180399A IL131803A0 (en) 1999-09-08 1999-09-08 Method for improving the efficiency of cancer gene therapy

Country Status (3)

Country Link
AU (1) AU7036900A (en)
IL (1) IL131803A0 (en)
WO (1) WO2001018056A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511759A (en) * 1997-06-26 2002-04-16 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル Target gene transfer using G protein-coupled receptor
DE69942207D1 (en) * 1998-08-25 2010-05-12 Merck Patent Gmbh Expression and export of angiostatin and endostatin as immunofusins

Also Published As

Publication number Publication date
AU7036900A (en) 2001-04-10
WO2001018056A2 (en) 2001-03-15
WO2001018056A3 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
EP1146912A4 (en) Method for improved radiation therapy
EP1406639A4 (en) Method for enhancing the effectiveness of cancer therapies
HUP0402656A3 (en) A cell therapy method for the treatment of tumors
AU2879300A (en) Methods for anti-tumor therapy
SI1176964T1 (en) Uses of et743 for treating cancer
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
PL345207A1 (en) Gene therapy method
MXPA03007036A (en) Method of cancer therapy.
GB2389532C (en) The method of treating cancer
AU7363000A (en) Method for reducing the risk of cancer
EP1401494A4 (en) Tumor therapy
GB0025890D0 (en) Gene therapy
IL149281A0 (en) Treatment of cancer
IL131803A0 (en) Method for improving the efficiency of cancer gene therapy
GB9900009D0 (en) Gene therapy
GB0406539D0 (en) Gene therapy
AU5778399A (en) Gene therapy for treatment of cancer
EP1225222A4 (en) Novel tumor suppressor gene
AU2616201A (en) Cancer treatment method
AU4552700A (en) Gene therapy
GB9910587D0 (en) Gene therapy
GB9920837D0 (en) Gene therapy
GB9819826D0 (en) Gene therapy method
GB9811836D0 (en) Gene therapy method
GB9814989D0 (en) Gene therapy method